Xylocor Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2013-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.xylocor.com
Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment (The EXACT Trial)
Phase 1
Completed
- Conditions
- IschemiaCardiovascular DiseasesHeart DiseasesCoronary Artery DiseaseAngina Refractory
- Interventions
- Biological: AdVEGFXC1
- First Posted Date
- 2019-10-14
- Last Posted Date
- 2024-01-30
- Lead Sponsor
- XyloCor Therapeutics, Inc.
- Target Recruit Count
- 41
- Registration Number
- NCT04125732
- Locations
- 🇺🇸
MedStar Washington Hospital Center, Washington, District of Columbia, United States
🇺🇸Cardiology Research Associates, Daytona Beach, Florida, United States
🇺🇸Emory University, Atlanta, Georgia, United States
© Copyright 2025. All Rights Reserved by MedPath